PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Stand Up To Cancer announces three teams focused on gastroesophageal cancer

Additional awards fund multi-year research projects targeting gastric, head and neck cancers and more

Stand Up To Cancer announces three teams focused on gastroesophageal cancer
2023-11-15
(Press-News.org) LOS ANGELES – Nov. 15, 2023 – Stand Up To Cancer® (SU2C) today announced three Research Teams focused on bringing new therapies to clinical trials for the treatment of gastroesophageal cancer (GEC). The Research Teams, a part of a Dream Team Collective supported by the Torrey Coast Foundation, will unite top researchers from 11 institutions to address critical problems in GEC prevention, diagnosis and treatment. The Dream Team Collective aims to foster new and inclusive cancer research on the causes and treatments of GEC, mentor a new generation of scientists focused on GEC, bring new treatments to the clinic, and provide medical professionals with tools and materials to better advocate for GEC screening and treatment with their patients.

 

SU2C also funded three 2023 Phillip A. Sharp Innovation in Collaboration Awards – which focus on bringing new perspectives together and encourage the inclusion of early-career investigators – and one SU2C Maverick Early Career Scientist Award – which is awarded to an investigator early in their career and supports a cutting-edge idea that has great potential to impact patient care. One of the Phillip A. Sharp Awards includes the Ziskin Prize, which honors legendary Hollywood producer and SU2C co-founder Laura Ziskin, who passed from breast cancer in 2011.
 

“SU2C is constantly seeking out the most promising research opportunities to support our effort to bring new and impactful cancer treatments to patients quickly,” said Julian Adams, Ph.D., SU2C’s chief science officer. “I’m excited about each of these new grants as they push critical studies forward and will greatly expand our understanding of cancer – specifically subtypes that are more difficult to treat.”
 

The SU2C-Torrey Coast Foundation Gastroesophageal Cancer Dream Team Collective includes:
 

Targeting Immune Evasion in Gastroesophageal Cancer – This team will focus on finding better treatment strategies for up to 70% of gastroesophageal cancer (GEC) patients for whom current treatments don’t work. Led by Yelena Janjigian, M.D., chief of the gastrointestinal oncology service at Memorial Sloan Kettering Cancer Center, and co-led by Jedd Wolchok, M.D., Ph.D., the Meyer Director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medicine, the team will investigate how GEC evades or suppresses the immune system. Focusing specifically on GEC that is characterized by chromosomal instability, which is associated with worse outcomes, metastasis and a resistance to current therapies, the team hopes to pinpoint drugs – or drug combinations – that can better treat GEC.
  Novel Therapeutic Approaches for Esophageal Squamous Cell Carcinoma – This team will focus on creating new therapeutic approaches for esophageal squamous cell carcinoma (ESCC). Led by Anil K. Rustgi, M.D., director at the Herbert Irving Comprehensive Cancer Center at Columbia University Irving Medical Center, and co-led by Kwok-Kin Wong, M.D., Ph.D., director of the Division of Hematology and Medical Oncology at NYU Langone’s Perlmutter Cancer Center, the team will investigate aspects of the local environment within and surrounding ESCC where it occurs in the body – including ESCC metastasis – to propose genetic characteristics that could potentially be targeted with new cancer therapies.
  Therapeutics for Gastroesophageal Adenocarcinoma: Application, Translation and Discovery – This team will focus on uncovering new therapies for gastroesophageal adenocarcinoma. Led by William Sellers, M.D., core institute member at Broad Institute of MIT and Harvard, and co-led by Marcela Maus, M.D., Ph.D., director of cellular immunotherapy at Massachusetts General Hospital’s Cancer Center, the team plans to define and target the cell surface of gastroesophageal adenocarcinoma and squamous cell carcinoma through a better understanding of the molecular makeup of these cancers. The team also plans to develop CAR-T cells – an immunotherapy that utilizes a patient’s own modified immune cells to fight cancer – for certain types of gastric and esophageal cancers.  

The Phillip A. Sharp Awards are:
 

The Phillip A. Sharp – Laura Ziskin Innovation in Collaboration Award: Development of microfluidic blood exchange as a next-generation parabiosis for tumor/microbiota immunology – This team will pair immunology with bioengineering to build upon current research that shows microbes residing within the human gut communicate with the immune system to enable anti-tumor responses to cancers. The team, led by Rabi Upadhyay, M.D., assistant professor at NYU Grossman School of Medicine and co-led by Scott Manalis, Ph.D., the David H. Koch professor in engineering at Massachusetts Institute of Technology, hopes to uncover ways in which gut microbes could be used in combination with other treatment strategies for future cancer therapies.  

The Phillip A. Sharp Innovation in Collaboration Award: Therapeutic biparatopic antibodies targeting FGFR2 in gastric cancer – This team will work to identify better treatments for the 30% of gastric cancer patients in which a certain protein called FGFR2 is overexpressed, which leads to lower survival rates. Led by Sandra Ryeom, Ph.D., associate professor at Columbia University and co-led by William Sellers, M.D., core institute member at Broad Institute of MIT and Harvard, the team will utilize gastric cancer organoids – which are small, simplified, three-dimensional tumors or organs grown in a lab – as well as other scientific methods to test medicines that deliver biologic therapies called ‘antibody drug conjugates’ with the goal of finding new therapies for FGFR2 positive gastric cancer patients.  

The Phillip A. Sharp Innovation in Collaboration Award: Defining immunotherapeutic potential in genome instability-driven squamous cell carcinomas – This team will build on currently funded SU2C research to identify new therapeutic options for Fanconi anemia patients, who are at a high risk of head and neck cancer and have few viable treatment options. Led by Agata Smogorzewska, M.D., Ph.D., professor at Rockefeller University, and Benjamin Greenbaum, Ph.D., director of computational immune-oncology at Memorial Sloan Kettering Cancer Center, the team will evaluate the likelihood that certain cancers – including head and neck cancer – will respond to immune-based therapies.  

The 2023 SU2C Maverick Award is:

 

AI for Targeting Undefined Molecular Subtypes of Head/Neck Cancer – This award will fund work to better understand the subgroups of head and neck squamous cell carcinoma (HNSCC) with the goal of informing better treatment strategies. Maverick Award winner Alexander Pearson, M.D., Ph.D., associate professor of medicine at University of Chicago, will utilize artificial intelligence to combine various types of disease information – including DNA, digital images of head and neck cancer tumors, and other datasets – to produce a comprehensive representation of HNSCC.  

 

 

#  #  #

 

Media Contact:                          

Mirabai Vogt-James

mjames@su2c.org

 

ABOUT STAND UP TO CANCER

 

Stand Up To Cancer® (SU2C) raises funds to accelerate the pace of research to get new therapies to patients quickly and save lives now. SU2C is a 501(c)(3) charitable organization and was initially launched as a division of the Entertainment Industry Foundation. Established in 2008 by media and entertainment leaders, SU2C utilizes these communities’ resources to engage the public in supporting a new, collaborative model of cancer research, to increase awareness about cancer prevention, and to highlight progress being made in the fight against the disease. As of April 2023, more than 3,000 scientists representing more than 210 institutions are involved in SU2C-funded research projects.

 

As SU2C’s scientific partner, the American Association for Cancer Research (AACR) and a Scientific Advisory Committee, led by Nobel laureate Phillip A. Sharp, Ph.D., conduct rigorous competitive review processes to identify the best research proposals to recommend for funding, oversee grants administration, and provide expert review of research progress.

 

Current members of the SU2C Founders and Advisors Committee (FAC) include Katie Couric, Sherry Lansing, Kathleen Lobb, Lisa Paulsen, Rusty Robertson, Sue Schwartz, Pamela Oas Williams, and Ellen Ziffren. The late Laura Ziskin and the late Noreen Fraser are also co-founders. Russell Chew serves as SU2C’s president and CEO.

 

For more information, visit StandUpToCancer.org, Instagram, TikTok, Twitter,  Facebook, and YouTube.

END


[Attachments] See images for this press release:
Stand Up To Cancer announces three teams focused on gastroesophageal cancer

ELSE PRESS RELEASES FROM THIS DATE:

Should a hospital invest toward specializing in an area? Or diversify? The impact of a hospital’s portfolio strategy on patient demand

2023-11-15
Researchers from Indiana University and Texas Christian University published a new Journal of Marketing study that examines the impact of a hospital’s portfolio strategy on patient demand. The study, forthcoming in the Journal of Marketing, is titled “Hospital Portfolio Strategy and Patient Choice” and is authored by Sarang Sunder and Sriram Thirumalai. Structural changes in the healthcare industry (e.g., the institution of the Affordable ...

Surveilling wetlands for infectious bird flu — and finding it

Surveilling wetlands for infectious bird flu — and finding it
2023-11-15
Recently, morning omelets and holiday dinners have gotten more expensive. One likely cause is bird flu, outbreaks of which led to the deaths of millions of chickens and turkeys from infection or culling in 2022, according to the U.S. Department of Agriculture, and which still demands rigorous monitoring of wild populations. Now, reporting in Environmental Science & Technology Letters, researchers have developed a method that detected infectious bird flu virus in wetlands frequented by waterfowl. Wild birds represent a significant reservoir of avian influenza ...

Not so silver lining: Microplastics found in clouds could affect the weather

2023-11-15
From the depths of the seas to snow on mountains and even the air above cities, microplastics are turning up increasingly often. Now, in ACS’ Environmental Science & Technology Letters, researchers have analyzed microplastics in clouds above mountains. They suggest that these tiny particles could play a role in cloud formation and, in turn, affect weather. Microplastics — plastic fragments smaller than five millimeters — originate from a myriad of items used daily, such as clothing, packaging and car tires. As research in the field evolves, scientists are not only detecting microplastics in the atmosphere but also investigating how they may play a role in cloud formation. ...

Association of molecular subtypes in bladder cancer with response to neoadjuvant chemotherapy, progression, and survival

Association of molecular subtypes in bladder cancer with response to neoadjuvant chemotherapy, progression, and survival
2023-11-15
Considering the molecular subtype of muscle-invasive bladder cancer (MIBC) based on differences in tumor RNA expression can improve the ability of an existing tumor biomarker such as the COXEN score to predict which patients’ tumors are likely to respond to chemotherapy given before surgery. Individual molecular subtypes, however, were not associated with significant differences in patients’ overall survival (OS) or progression-free survival (PFS) times. Those are the conclusions from a secondary analysis of data from the S1314 clinical trial, a large study in patients with MIBC that was conducted by the SWOG Cancer Research Network, a clinical trials group funded by ...

Colliding ribosomes activate RNA repair

2023-11-15
Aldehydes are toxic compounds that are produced in the body by metabolic processes, especially upon alcohol consumption. They are dangerous because they bind to cellular macromolecules such as DNA, RNA, and proteins, and crosslink them.   Crosslinking damage to DNA must be repaired by the cell to prevent premature aging and cancer. However, it was previously unknown whether and how cells sense and resolve crosslinking damage to single-stranded RNA. A team led by Professor Julian Stingele from ...

On two small islands in the Indian Ocean, an endangered palm with the world’s largest seed sows a lesson about landscape restoration

On two small islands in the Indian Ocean, an endangered palm with the world’s largest seed sows a lesson about landscape restoration
2023-11-15
Every tree species has its story. Unraveling all 73,000 of them is a significant undertaking for science, in no small part because a considerable proportion of tree biodiversity is tropical, rare, remote and subject to the ravages of deforestation. And an estimated 9,200 tree species have yet to be discovered. Even trees well-known to science have mysteries. One is the Seychelles’ endangered coco de mer, or sea coconut palm tree, which is now relegated to parts of two small Indian Ocean islands and in decline. Only some 8,200 individuals remain. What Lodoicea madivica lacks in range it makes ...

New scientific study reveals the crucial role of herbivorous fishes and sea urchins in restoring Caribbean coral reefs

New scientific study reveals the crucial role of herbivorous fishes and sea urchins in restoring Caribbean coral reefs
2023-11-15
A new study by Dr. Lindsay Spiers (Florida Fish and Wildlife Conservation Commission) and Professor Thomas Frazer (College of Marine Science at the University of South Florida), published in PeerJ Life & Environment, presents crucial findings on the feeding preferences of herbivorous fishes and the sea urchin Diadema antillarum in Little Cayman. The study, titled "Comparison of feeding preferences of herbivorous fishes and the sea urchin Diadema antillarum in Little Cayman," sheds new light on the dynamics of these herbivores and their impact on the resilience of Caribbean coral reefs. Caribbean coral reefs face significant challenges, ...

The Future of Future Earth: How global science programs can navigate the complex, shifting challenges in sustainability science

The Future of Future Earth: How global science programs can navigate the complex, shifting challenges in sustainability science
2023-11-15
The global change program Future Earth is an international alliance of organizations and agencies that was launched by the UN in June 2012. The Future Earth 2025 Vision identified eight global challenges for scientific research to accelerate progress in sustainability, improve collaboration, and mobilize resources. After more than a decade of this global change program, researchers are analyzing the challenges Future Earth has faced and the path forward. Discussion presented in a recently published paper reviews these challenges faced by the coalition and proposes solutions to help these programs meet the many needs of the global community. The paper was published on ...

Georgetown Global Health Center launches first open-access wildlife disease database

2023-11-15
WASHINGTON (November 15, 2023) – Georgetown University Medical Center’s Center for Global Health Science and Security (GHSS) today announces the launch of a first-of-its-kind wildlife disease database -- a system for collecting records of viruses, bacteria, fungi, parasites, etc. -- designed to support an early warning system for potential viral emergence. The Pathogen Harmonized Observatory, or PHAROS, is open to the global community and free to access. Scientists in GHSS’ Verena program, a collaborative ...

University of Basel delivers first biological implants for treatment of cartilage lesions and osteoarthritis in humans

University of Basel delivers first biological implants for treatment of cartilage lesions and osteoarthritis in humans
2023-11-15
The Department of Biomedicine at the University of Basel and the University Hospital Basel, today announced that it delivered the first surgical procedure to treat Osteoarthritis (OA) in humans. The procedure called Nasal Chondrocyte Tissue-Engineered Cartilage, or N-TEC, provides an innovative alternative to cure confined knee cartilage lesions as well as to address degenerative OA cases that have to date required knee joint replacements – prosthetics that routinely need replacing after 15-20 years. The team at Basel is spearheading the next-generation human clinical trials that will ...

LAST 30 PRESS RELEASES:

Scientists unlock secrets behind flowering of the king of fruits

Texas A&M researchers illuminate the mysteries of icy ocean worlds

Prosthetic material could help reduce infections from intravenous catheters

Can the heart heal itself? New study says it can

Microscopic discovery in cancer cells could have a big impact

Rice researchers take ‘significant leap forward’ with quantum simulation of molecular electron transfer

Breakthrough new material brings affordable, sustainable future within grasp

How everyday activities inside your home can generate energy

Inequality weakens local governance and public satisfaction, study finds

Uncovering key molecular factors behind malaria’s deadliest strain

UC Davis researchers help decode the cause of aggressive breast cancer in women of color

Researchers discovered replication hubs for human norovirus

SNU researchers develop the world’s most sensitive flexible strain sensor

Tiny, wireless antennas use light to monitor cellular communication

Neutrality has played a pivotal, but under-examined, role in international relations, new research shows

Study reveals right whales live 130 years — or more

Researchers reveal how human eyelashes promote water drainage

Pollinators most vulnerable to rising global temperatures are flies, study shows

DFG to fund eight new research units

Modern AI systems have achieved Turing's vision, but not exactly how he hoped

Quantum walk computing unlocks new potential in quantum science and technology

Construction materials and household items are a part of a long-term carbon sink called the “technosphere”

First demonstration of quantum teleportation over busy Internet cables

Disparities and gaps in breast cancer screening for women ages 40 to 49

US tobacco 21 policies and potential mortality reductions by state

AI-driven approach reveals hidden hazards of chemical mixtures in rivers

Older age linked to increased complications after breast reconstruction

ESA and NASA satellites deliver first joint picture of Greenland Ice Sheet melting

Early detection model for pancreatic necrosis improves patient outcomes

Poor vascular health accelerates brain ageing

[Press-News.org] Stand Up To Cancer announces three teams focused on gastroesophageal cancer
Additional awards fund multi-year research projects targeting gastric, head and neck cancers and more